Stay updated on Pembrolizumab in cSCC: Recurrent/Metastatic Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in cSCC: Recurrent/Metastatic Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in cSCC: Recurrent/Metastatic Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Publications section updated with clarifications that publications are provided voluntarily by the study entry author and are auto-filled from PubMed; the Revision: v3.3.2 note is now shown.
    Difference
    0.1%
    Check dated 2025-11-24T17:08:49.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The government funding lapse notice was removed from the page; the rest of the study information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T15:05:32.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    Expanded location list and a new last update date, while enrollment remains 159 and there are no changes to primary outcomes or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:32:58.000Z thumbnail image
  5. Check
    64 days ago
    Change Detected
    Summary
    The page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-05T10:34:09.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The page updates the revision from v3.0.2 to v3.1.0, indicating a new version is available. If there is additional content tied to the release, it isn’t shown here.
    Difference
    0.1%
    Check dated 2025-09-28T03:22:55.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1, and the 'Back to Top' element has been removed.
    Difference
    0.1%
    Check dated 2025-09-13T17:40:07.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in cSCC: Recurrent/Metastatic Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in cSCC: Recurrent/Metastatic Clinical Trial page.